Changes lie ahead for the top of the Supervisory Board for the specialty chemicals company LANXESS. The Board’s current Chairman, Dr. Rolf Stomberg (77) will resign from his office as a member and Chairman of the Supervisory Board after the end of the Annual Stockholders’ Meeting on May 15, 2018. “When I was re-elected to the Supervisory Board in 2015, I announced support for the realignment of LANXESS, but that I would not hold office the entire term. Now the company is doing well and is back on track for growth – it is the right time to leave the Chair of the Supervisory Board to someone new,” said Stomberg. Stomberg has recommended Dr. Matthias L. Wolfgruber (64) to succeed him for the position of Chairman of the Supervisory Board. Wolfgruber has a doctorate in chemistry, served as Chairman of the Board of Management of Altana AG, and has belonged to the supervisory body as a representative for stockholders since 2015. The new chairman will be elected by the Supervisory Board at its constituent, first meeting after the Annual Stockholders’ Meeting in 2018. Pamela Knapp (60) is expected to be promoted as a new member to the Supervisory Board for LANXESS. Her election will be recommended to stockholders at the Annual Stockholders’ Meeting on May 15, 2018. She graduated in Economics and most recently served as the Chief Financial Officer (CFO) for GfK SE, the listed market research company based in Nuremberg, Germany. Prior to that, she was active in various management roles at the Siemens Group.
Chairman of chemicals company Lanxess Dr Rolf Stomberg will resign from the supervisory board after the annual stockholders' meeting on 15 May, and will be replaced by Dr Matthias L Wolfgruber. Dr Stomberg was re-elected to the board in 2015 knowing that he didn't intend to hold office the entire term, and he feels that now is the right time to leave given that the company is back on track for growth. Dr Wolfgruber has a doctorate in chemistry and was recommended by his predecessor.